William Blair Investment Management
ANIP icon

William Blair Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

William Blair Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.4M Sell
258,173
-69,103
-21% -$5.54M 0.06% 242
2026
Q1 		$25.2M Buy
327,276
+10,583
+3% +$826K 0.08% 223
2025
Q4 		$25M Sell
316,693
-31,987
-9% -$2.77M 0.07% 242
2025
Q3 		$31.9M Sell
348,680
-141,856
-29% -$11.6M 0.08% 201
2025
Q2 		$32M Sell
490,536
-37,740
-7% -$2.46M 0.08% 193
2025
Q1 		$35.4M Buy
528,276
+43,008
+9% +$2.57M 0.1% 184
2024
Q4 		$26.8M Buy
485,268
+10,440
+2% +$599K 0.07% 273
2024
Q3 		$28.3M Sell
474,828
-14,558
-3% -$888K 0.07% 248
2024
Q2 		$31.2M Sell
489,386
-879
-0.2% -$57.1K 0.08% 214
2024
Q1 		$33.9M Sell
490,265
-292
-0.1% -$17.6K 0.09% 223
2023
Q4 		$27M Sell
490,557
-9,502
-2% -$523K 0.08% 248
2023
Q3 		$29M Sell
500,059
-39,069
-7% -$2.25M 0.1% 224
2023
Q2 		$29M Buy
539,128
+9,998
+2% +$443K 0.09% 236
2023
Q1 		$21M Buy
529,130
+1,665
+0.3% +$70.2K 0.07% 276
2022
Q4 		$21.2M Sell
527,465
-19,924
-4% -$748K 0.08% 255
2022
Q3 		$17.6M Sell
547,389
-9,665
-2% -$331K 0.07% 266
2022
Q2 		$16.5M Sell
557,054
-14,126
-2% -$407K 0.06% 276
2022
Q1 		$16.1M Buy
571,180
+119,736
+27% +$4.46M 0.05% 304
2021
Q4 		$20.8M Buy
451,444
+77,338
+21% +$3.32M 0.06% 292
2021
Q3 		$12.3M Buy
374,106
+373,351
+49,450% +$11.6M 0.03% 349
2021
Q2 		$26K Buy
+755
New +$25.7K ﹤0.01% 461

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management's ANIP Position: Q2 2026 in Review

William Blair Investment Management reduced its ANI Pharmaceuticals (ANIP) stake by 21% in Q2 2026, selling an estimated $5.54M and leaving 258,173 shares worth $21.4M. The position accounts for 0.06% of the portfolio, ranked #242.

William Blair Investment Management first reported a position in ANIP in Q2 2021 and has held it in 21 quarters since. The position peaked at $35.4M in Q1 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • William Blair Investment Management held 258,173 shares of ANI Pharmaceuticals worth $21.4M as of Q2 2026.
  • William Blair Investment Management sold 69,103 ANI Pharmaceuticals shares in Q2 2026, an estimated $5.54M.
  • ANI Pharmaceuticals made up 0.06% of William Blair Investment Management's portfolio in Q2 2026, its #242 holding.
  • William Blair Investment Management first reported a position in ANI Pharmaceuticals in Q2 2021 and has held it in 21 quarters since.
  • William Blair Investment Management's ANI Pharmaceuticals position peaked at $35.4M in Q1 2025.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on William Blair Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.